“…Therefore, gut microbiota analysis is a new Frontier for understanding the action mechanisms of TCMs (Feng et al, 2019). Studies have shown that GQD has antidiarrheal (Liu et al, 2019b;Hua et al, 2019), anti-colitis (Xu B.-L. et al, 2015;Li et al, 2016;Fan et al, 2019;Zhao Y. et al, 2020), anti-nonalcoholic fatty liver disease (NAFLD) Guo et al, 2017;Guo et al, 2018;Hao et al, 2020;Zhang et al, 2020), antidiabetic (Zhang et al, 2013;Cao et al, 2020;Tu et al, 2020), anti-lung injury (Ding et al, 2020;Shi et al, 2020), antitumor (Wang N. et al, 2015;Lv et al, 2019) and other pharmacological effects. Metabolomics (Tian et al, 2013;Hua et al, 2019), network pharmacology (Li et al, 2014b;Cao et al, 2020;Ding et al, 2020;Hao et al, 2020;Xu et al, 2020;Zhong et al, 2020), gut microbiota analysis Guo et al, 2018;Liu et al, 2019b;Lv et al, 2019), and other methods have been comprehensively used to explain the action mechanism of GQD.…”